Infectious Disease Alert – November 1, 2007
November 1, 2007
View Archives Issues
-
Viruses Across the World
Between july 4th and august 28th 2007, more than 100 residents of Castiglione di Cervia and Castiglione di Ravenna, adjacent villages separated by the River Savio, suffered acute febrile illnesses with myalgias, arthralgis, and frequently, skin rash. -
Micafungin for Invasive Candidiasis
Micafungin at doses of both 100 mg and 150 mg daily was non-inferior to caspofungin in the treatment of invasive candidiasis and there was no significant difference in outcomes when the two doses of micafungin were compared. -
The Impact of Prescribing Antibiotics to Children
Prescribing β-lactam antibiotics for children with upper respiratory tract infections is associated with in a 3-fold increase in the MIC for ampicillin and 2-fold increase of the ICEHin1056 resistance gene of oropharyngeal Haemophilus isolates. -
Culture-Negative Prosthetic Joint Infection
A retrospective cohort study of culture-negative (CN) prosthetic joint infection (PJI) was performed on patients who underwent total hip or total knee arthroplasty at Mayo Clinic from 1990-1999. -
Cholera Cases: Past, Present, and Future
Although imported cholera cases in developed countries, such as France, may continue to decline, the global number of cholera cases continues to rise at an alarming rate. Orally administered cholera vaccine may hold promise in controlling cholera epidemics. -
Quadrivalent HPV Vaccine as a Travel Vaccine
In June, 2006, the FDA licensed the first human papillomavirus vaccine (HPV) to prevent cervical cancer and other HPV-associated cancers: vaginal, urethral, and oral tumors. Is this yet another travel vaccine for our patients? -
Updates By Carol A. Kemper, MD, FACP
A military serviceman stationed in Hawaii, presented to base with intense pruritus, restlessness, dyspnea, and progressive paresthesias, with burning skin discomfort. -
Pharmacology Watch: Are Thiazolidinediones (TZDs) Safe?
Are thiazolidinediones safe? New study shows Zometa reduces risk of hip fractures and improves survival. -
Clinical Briefs in Primary Care supplement